ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults
Clinical trial NCT04856865 · COMPLETED
Trial details
- NCT number
- NCT04856865
- Sponsor
- Alladapt Immunotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-11-22
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.